Who are the key manufacturers in the Platelet Rich Plasma market?
The global platelet rich plasma market size was estimated at USD 476.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12.0% from 2021 to 2028. Platelet rich plasma (PRP) is proven to be a prominent source of antilogous products in the field of regenerative medicine and a true precursor for the healing process along with scaffold and stem cells. An increase in the incidence of sports injuries and orthopedic diseases are set to propel the demand for PRP therapy. The expanding research base is expected to boost the demand for platelet rich plasma preparation products. The application of PRP products in the treatment of musculoskeletal conditions, orthopedic disorders, and sports injuries has become more prevalent over recent years. Several research studies have observed that the increased concentration of growth factors in platelet rich plasma has the ability to potentially accelerate the healing process. This has proven to be a major source of autolo...